ML264: An Antitumor Agent that Potently and Selectively Inhibits Krüppel-like Factor Five (KLF5) Expression: A Probe for Studying Colon Cancer Development and Progression

Agnieszka Bialkowska  1 ,  Melissa Crisp  2 ,  Franck Madoux  2 ,  Tim Spicer  2 ,  Ania Knapinska  2 ,  Becky Mercer  2 ,  Thomas D. Bannister  3 ,  Yuanjun He  3 ,  Sarwat Chowdhury  3 ,  Michael Cameron  4 ,  Vincent W. Yang  1 ,  Peter Hodder  2  4
Affiliations
  • 1. Emory University (current affiliation Stony Brook University School of Medicine)
  • 2. The Scripps Research Institute, Lead Identification Division, Jupiter, FL
  • 3. The Scripps Research Institute, Department of Chemistry, Jupiter, FL
  • 4. Department of Molecular Therapeutics, Jupiter, FL
PMID: 23762940
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-19994
    ML264
    98.32%, KLF5 Inhibitor
    target: KLF
    Research Areas: Cancer